Financing the Future
Sorbie Bornholm:
Investing In Your Goals
Sorbie Bornholm is a global investment firm that provides funding for ongoing business objectives to listed micro, small and mid-cap growth companies.
We focus on equity investments in companies that are already listed and looking to expand. Our extensive experience allows us to invest in most industries. Allowing us to focus on providing supportive, longer term capital that rewards company growth.
The Sorbie-Strategy
Small-Cap
Mid-Cap
Funded
Growth
Upward Trends Funded
Our shareholdings are typically medium to longer term. As a company’s share price increases, more cash is delivered at no additional cost. Therefore becoming a very cheap source of capital for companies that grow their share price.
Many companies in which Sorbie Bornholm has invested have received more cash in addition to the initial Sorbie Bornholm investment, without issuing any additional shares.
The Principle of Upward Trends
Values Help Build Your Success
Our core values drive who we are and how we invest. Committed to developing long-term relationships with select listed public companies and their brokers & advisers.
Focused on providing supportive, longer term capital that rewards growth. At Sorbie Bornholm, we invest to make a difference, to become a valued partner and to be a shareholder of choice. It’s important to us that we succeed together.
Sorbie-Strategy Success Stories
Mining & Mineral Extraction
Kogi Iron
Pharmaceutical & Biotechnology
Neuren Pharmaceuticals
Mining & Mineral Extraction
KEFI Minerals
Testimonials
“Our long standing relationship with Sorbie has provided us with continuous access to capital with non-dilutive upside as we grow and execute as a company. We are proud to have Sorbie as a supportive shareholder as we look to advance our projects towards development.”
“This is a very important financing… [that] enables Neuren to benefit with share price appreciation. Now we can focus on our meeting with the FDA and the preparations for a Phase 3 trial. Neuren Pharmaceuticals is pleased to have a new supportive institutional shareholder.”
“We have continued to advance our Tulu Kapi gold project, and are now at a pivotal stage of the company’s development. The proceeds of the fundraising will underpin the activities for the whole of 2017 as we look to start development of this quality project during the year.”
Deals Done Using the Sorbie-Strategy
Our Latest News
Sorbie Bornholm Announces Tocvan Ventures Corp. Received 80% Additional Cash from the Sharing Agreement
London, UK – 10 October 2025 – Sorbie Bornholm LP (“Sorbie”), a UK investment fund, is pleased to announce that Tocvan Ventures Corp. (“Tocvan”) (CSE: TOC; OTCQB: TCVNF; WKN: TV3/A2PE64) has received increased cash in its most recent monthly settlement under the two...
Sorbie Bornholm Announces ARES Receives 17% Additional Cash Sharing Agreement
London, UK – 22 September 2025 – Sorbie Bornholm LP (“Sorbie”), a UK-based investment fund, is pleased to announce that Ares Strategic Mining Inc. (CSE: ARS; FRA: N8I1; OTC: ARSMF) has once again received additional cash from its Sharing Agreement with Sorbie —...
Sorbie Bornholm Announces Tocvan Ventures Corp. Received 83% Additional Cash from the Sharing Agreement
London, UK – 5 September 2025 – Sorbie Bornholm LP (“Sorbie”), a UK investment fund, is pleased to announce that Tocvan Ventures Corp. (“Tocvan”) (CSE: TOC; OTCQB: TCVNF; WKN: TV3/A2PE64) has received increased cash in its most recent monthly settlement under the two...
Let Us Help You Succeed
Let's talk and see if the Sorbie-Strategy is right for your company. At Sorbie Bornholm, we've helped many businesses succeed – and we'd love to help your listed business too.
contact@sorbiebornholm.com
11075 S State, Blg 4
Sandy, UT 84070
+1 (801) 895-3700